ArticleRSC advances2025

Development of substituted 2-(4-(sulfonyl)piperazin-1-yl)quinazoline molecular hybrids as a new class of antimalarials.

Hari Madhav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.